Search research articles
Contact Us
Filters
Showing results (1-10 of 31) with videos related to
Page
of 4
Sort By:
Genes & Cancer
|
May 2, 2013
Mitotic Stress and Chromosomal Instability in Cancer: The Case for TPX2
Ignacio Pérez de Castro, Marcos Malumbres
Expert Opinion on Therapeutic Targets
|
September 10, 2014
Aurora kinase A inhibitors: promising agents in antitumoral therapy
Marcos Malumbres, Ignacio Pérez de Castro
Cell Cycle (Georgetown, Tex.)
|
October 10, 2008
Control of cell proliferation pathways by microRNAs
María José Bueno, Ignacio Pérez de Castro, Marcos Malumbres
Carcinogenesis
|
January 30, 2007
A census of mitotic cancer genes: new insights into tumor cell biology and cancer therapy
Ignacio Pérez de Castro, Guillermo de Cárcer, Marcos Malumbres
Current Medicinal Chemistry
|
April 19, 2007
Targeting cell cycle kinases for cancer therapy
Guillermo de Cárcer, Ignacio Pérez de Castro, Marcos Malumbres
Current Opinion in Pharmacology
|
July 23, 2008
Emerging cancer therapeutic opportunities by inhibiting mitotic kinases
Ignacio Pérez de Castro, Guillermo de Cárcer, Guillermo Montoya, et al.
Cell Cycle (Georgetown, Tex.)
|
February 23, 2013
Aurora B prevents delayed DNA replication and premature mitotic exit by repressing p21(Cip1)
Marianna Trakala, Gonzalo Fernández-Miranda, Ignacio Pérez de Castro, et al.
Journal of Cellular Physiology
|
September 23, 2003
NF1 modulates the effects of Ras oncogenes: evidence of other NF1 function besides its GAP activity
Teresa Corral, María Jiménez, Inmaculada Hernández-Muñoz, et al.
Cancer Research
|
April 19, 2005
Mouse p10, an alternative spliced form of p15INK4b, inhibits cell cycle progression and malignant transformation
Ignacio Pérez de Castro, Marta Benet, María Jiménez, et al.
Cancer Research
|
September 3, 2004
The Rgr oncogene induces tumorigenesis in transgenic mice
María Jiménez, Ignacio Pérez de Castro, Marta Benet, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 31) with videos related to
Sort By:
Page
of 4
Genes & Cancer
|
May 2, 2013
Mitotic Stress and Chromosomal Instability in Cancer: The Case for TPX2
Ignacio Pérez de Castro, Marcos Malumbres
Expert Opinion on Therapeutic Targets
|
September 10, 2014
Aurora kinase A inhibitors: promising agents in antitumoral therapy
Marcos Malumbres, Ignacio Pérez de Castro
Cell Cycle (Georgetown, Tex.)
|
October 10, 2008
Control of cell proliferation pathways by microRNAs
María José Bueno, Ignacio Pérez de Castro, Marcos Malumbres
Carcinogenesis
|
January 30, 2007
A census of mitotic cancer genes: new insights into tumor cell biology and cancer therapy
Ignacio Pérez de Castro, Guillermo de Cárcer, Marcos Malumbres
Current Medicinal Chemistry
|
April 19, 2007
Targeting cell cycle kinases for cancer therapy
Guillermo de Cárcer, Ignacio Pérez de Castro, Marcos Malumbres
Current Opinion in Pharmacology
|
July 23, 2008
Emerging cancer therapeutic opportunities by inhibiting mitotic kinases
Ignacio Pérez de Castro, Guillermo de Cárcer, Guillermo Montoya, et al.
Cell Cycle (Georgetown, Tex.)
|
February 23, 2013
Aurora B prevents delayed DNA replication and premature mitotic exit by repressing p21(Cip1)
Marianna Trakala, Gonzalo Fernández-Miranda, Ignacio Pérez de Castro, et al.
Journal of Cellular Physiology
|
September 23, 2003
NF1 modulates the effects of Ras oncogenes: evidence of other NF1 function besides its GAP activity
Teresa Corral, María Jiménez, Inmaculada Hernández-Muñoz, et al.
Cancer Research
|
April 19, 2005
Mouse p10, an alternative spliced form of p15INK4b, inhibits cell cycle progression and malignant transformation
Ignacio Pérez de Castro, Marta Benet, María Jiménez, et al.
Cancer Research
|
September 3, 2004
The Rgr oncogene induces tumorigenesis in transgenic mice
María Jiménez, Ignacio Pérez de Castro, Marta Benet, et al.
Page
of 4